Full Text:  <695>

CLC number: R575.1

On-line Access: 2012-11-05

Received: 2012-06-27

Revision Accepted: 2012-09-27

Crosschecked: 2012-10-18

Cited: 0

Clicked: 1063

Citations:  Bibtex RefMan EndNOte GB/T7714

-   Go to

Article info.
1. Reference List
Open peer comments

Journal of Zhejiang University SCIENCE B 2012 Vol.13 No.11 P.948-954

doi: 10.1631/jzus.B1200179


Immunological effects of a 10-μg dose of domestic hepatitis B vaccine in adults


Author(s):  Jing-jing Ren, Xue-wei Dai, Zheng-gang Jiang, Ling-zhi Shen, Yong-di Chen, Qian Li, Wen Ren, Ying Liu, Jun Yao, Lan-juan Li

Affiliation(s):  1.State Key Laboratory for Diagnosis and Treatment of Infectious Disease, Key Laboratory of Infectious Diseases, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China; Department of Epidemiology and Statistics, School of Medicine, Ningbo University, Ningbo 315000, China; Zhejiang Center for Disease Control and Prevention, Hangzhou 310003, China; Department of Family Medicine, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China

Corresponding email(s):  jyao@CDC.zj.cn , Ljli@zju.edu.cn

Key Words:  Hepatitis B, Vaccines, Immunization, Geometric mean titer


Share this article to? More

Jing-jing Ren, Xue-wei Dai, Zheng-gang Jiang, Ling-zhi Shen, Yong-di Chen, Qian Li, Wen Ren, Ying Liu, Jun Yao, Lan-juan Li. Immunological effects of a 10-μg dose of domestic hepatitis B vaccine in adults[J]. Journal of Zhejiang University Science B, 2012, 11(13): 948-954.

@article{0
title="Immunological effects of a 10-μg dose of domestic hepatitis B vaccine in adults",
author="Jing-jing Ren, Xue-wei Dai, Zheng-gang Jiang, Ling-zhi Shen, Yong-di Chen, Qian Li, Wen Ren, Ying Liu, Jun Yao, Lan-juan Li",
journal="Journal of Zhejiang University Science B",
volume="13",
number="11",
pages="948-954",
year="2012",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B1200179"
}

%0 Journal Article
%T Immunological effects of a 10-μg dose of domestic hepatitis B vaccine in adults
%A Jing-jing Ren
%A Xue-wei Dai
%A Zheng-gang Jiang
%A Ling-zhi Shen
%A Yong-di Chen
%A Qian Li
%A Wen Ren
%A Ying Liu
%A Jun Yao
%A Lan-juan Li
%J Journal of Zhejiang University SCIENCE B
%V 13
%N 11
%P 948-954
%@ 1673-565X
%D 2012
%I Zhejiang University Press & Springer

TY - JOUR
T1 - Immunological effects of a 10-μg dose of domestic hepatitis B vaccine in adults
A1 - Jing-jing Ren
A1 - Xue-wei Dai
A1 - Zheng-gang Jiang
A1 - Ling-zhi Shen
A1 - Yong-di Chen
A1 - Qian Li
A1 - Wen Ren
A1 - Ying Liu
A1 - Jun Yao
A1 - Lan-juan Li
J0 - Journal of Zhejiang University Science B
VL - 13
IS - 11
SP - 0
EP - 0
SN - 1673-565X
Y1 - 2012
PB - Zhejiang University Press & Springer
ER -


Abstract: 
Objective: To evaluate the immunological effects of three types of domestic 10-µg/dose hepatitis B vaccines in adults compared with a foreign vaccine, and to provide scientific evidence in support of adult hepatitis B vaccination. Methods: Adults from five counties (Deqing, Changxing, Nanxun, Wuxing, Anji) in Huzhou City, Shaoxing County and Tongxiang County, Zhejiang Province, China were selected. Blood samples were taken to assess serum HBsAg, anti-HBs, and anti-HBc using a chemiluminescence immunoassay. Adults, aged 16 to 49 years and who were anti-HBs negative at baseline, received hepatitis B immunizations at 0, 1, and 6 months. Anti-HBs levels were assessed one month after the third and final vaccination. Results: A total of 1872 adults were immunized and the average positive rate was 89.5%. Four types of hepatitis B vaccine were used, including three from Chinese companies (Shenzhen Kangtai, Dalian High-Tech, and North China Pharmaceutical) and one from a UK company (GlaxoSmithKline). Their seroconversion rates were 81.67%, 95.05%, 89.64%, and 86.81%, respectively. There was a significant difference between the anti-HBs positive conversion rates of the four types (P<0.005) but the seroconversion rates among the different vaccines were not significantly different (χ2=2.123, P=0.145). The average anti-HBs geometric mean titers (GMTs) of non-immune adults immunized with each of the four vaccines were 177.28, 473.23, 246.13, and 332.20 mIU/ml, respectively. There were no statistically significant differences in the GMTs between the three types of domestic vaccine and the foreign vaccine (t=−1.575, P=0.116). Conclusions: Domestic recombinant hepatitis B vaccines can achieve immunization effects comparable to those of a foreign vaccine.

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article

Reference

[1]Bonanni, P., 1995. Implementation in Italy of a universal vaccination programme against hepatitis B. Vaccine, 13(s1):68-71.

[2]Bryan, J.P., Craig, P.G., Reyes, L., Hakre, S., Jaramillo, R., Harlan, H., MacArthy, P., Legters, L.J., 1995. Randomized comparison of 5 and 10 microgram doses of two recombinant hepatitis B vaccines. Vaccine, 13(11):978-982.

[3]Chang, M.H., Hadzic, D., Rouassant, S.H., Jonas, M., Kohn, I.J., Negro, F., Roberts, E., Sibal, A., 2004. Acute and chronic hepatitis: Working Group Report of the Second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J. Pediatr. Gastroenterol. Nutr., 39(s2):584-588.

[4]Coates, T., Wilson, R., Patrick, G., Andre, F., Watson, V., 2001. Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines. Clin. Ther., 23(3):392-403.

[5]Daniels, D., Grytdal, S., Wasley, A., 2009. Surveillance for acute viral hepatitis―United States, 2007. MMWR Surveill. Summ., 58(3):1-27.

[6]Dong, M.H., Lin, Y.D., Qian, Y.H., Jiang, Y., Deng, Y., Ding, S., Ren, Y.J., 2009. Immunity effect of homemade recombinant yeast-derived hepatitis B vaccine in adults. Mod. Med. J. China, 11(2):24-26.

[7]Ganczak, M., Szych, Z., Korzen, M., 2009. Preoperative vaccination for HBV at Polish hospitals as a possible public health tool to limit the spread of the epidemic: a cross-sectional study. Vaccine, 27(30):3969-3974.

[8]Ganem, D., Prince, A.M., 2004. Hepatitis B virus infection―natural history and clinical consequences. N. Engl. J. Med., 350(11):1118-1129.

[9]Gilbert, C.L., Klopfer, S.O., Martin, J.C., Schodel, F.P., Bhuyan, P.K., 2011. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years. Hum. Vaccin, 7(12):1336-1342.

[10]Goldstein, S.T., Zhou, F., Hadler, S.C., Bell, B.P., Mast, E.E., Margolis, H.S., 2005. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int. J. Epidemiol., 34(6):1329-1339.

[11]Gong, X.Y., Zhong, J.Y., 2009. Evaluation of Immunogenicity of 10 µg Recombinant yeast-derived hepatitis B vaccine in adults. China Prevent Med., 10(10):934-936 (in Chinese).

[12]Jilg, W., Schmidt, M., Deinhardt, F., 1988. Persistence of specific antibodies after hepatitis B vaccination. J. Hepatol., 6(2):201-207.

[13]Lavanchy, D., 2004. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepat., 11(2):97-107.

[14]Liang, X., Bi, S., Yang, W., Wang, L., Cui, G., Cui, F., Zhang, Y., Liu, J., Gong, X., Chen, Y., et al., 2009a. Epidemiological serosurvey of hepatitis B in China― declining HBV prevalence due to hepatitis B vaccination. Vaccine, 27(47):6550-6557.

[15]Liang, X., Bi, S., Yang, W., Wang, L., Cui, G., Cui, F., Zhang, Y., Liu, J., Gong, X., Chen, Y., et al., 2009b. Evaluation of the impact of hepatitis B vaccination among children born during 1992–2005 in China. J. Infect. Dis., 200(1):39-47.

[16]Lu, F.M., Zhuang, H., 2009. Management of hepatitis B in China. Chin. Med. J. (Engl.), 122(1):3-4.

[17]Mast, E.E., Mahoney, F.J., Alter, M.J., Margolis, H.S., 1998. Progress toward elimination of hepatitis B virus transmission in the United States. Vaccine, 16(Suppl.):48-51.

[18]Mast, E.E., Weinbaum, C.M., Fiore, A.E., Alter, M.J., Bell, B.P., Finelli, L., Rodewald, L.E., Douglas, J.M.Jr., Janssen, R.S., Ward, J.W., 2006. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Part II: immunization of adults. MMWR Recomm. Rep., 55(RR-16):1-33, quiz CE31-CE34.

[19]Rendi-Wagner, P., Kundi, M., Stemberger, H., Wiedermann, G., Holzmann, H., Hofer, M., Wiesinger, K., Kollaritsch, H., 2001. Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience. Vaccine, 19(15-16):2055-2060.

[20]Shen, L.Z., Yao, J., 2011. Study development on booster immune strategy of hepatitis B vaccine. Zhejiang J. Prevent. Med., 23(12):22-25 (in Chinese).

[21]Trivello, R., Chiaramonte, M., Ngatchu, T., Baldo, V., Majori, S., Moschen, M.E., Simoncello, I., Renzulli, G., Naccarato, R., 1995. Persistence of anti-HBs antibodies in health care personnel vaccinated with plasma-derived hepatitis B vaccine and response to recombinant DNA HB booster vaccine. Vaccine, 13(2):139-141.

[22]Weinbaum, C.M., Williams, I., Mast, E.E., Wang, S.A., Finelli, L., Wasley, A., Neitzel, S.M., Ward, J.W., 2008. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm. Rep., 57(RR-8):1-20.

[23]WHO (World Health Organization), 2000. Hepatitis B. WHO, Geneva, Switzerland. Available from http://www.who.int/mediacentre/factsheets/fs204/en [Accessed on 2 June 2010].

[24]Yao, J., Chen, Y.D., 2009. Immunity effect of domestic hepatitis B vaccine in adults. China Prevent Med., 10(4):258-261 (in Chinese).

[25]Yao, J., Ren, J.J., Shen, L.Z., Chen, Y.D., Liang, X.F., Cui, F.Q., Li, Q., Jiang, Z.G., Wang, F.Z., 2011. The effects of booster vaccination of hepatitis B vaccine on anti-HBV surface antigen negative children 11–15 years after primary vaccination. Hum. Vaccin., 7(10):1055-1059.

[26]Young, M.D., Gooch, W.M.3rd, Zuckerman, A.J., Du, W., Dickson, B., Maddrey, W.C., 2001. Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination. J. Med. Virol., 64(3):290-298.

[27]Yuan, Y.B., Zheng, X.H., Wang, Z.Q., 2003. Study on the immuno-effects and security of Chinese Hamster Ovary (CHO) cell hepatitis B vaccine among adults, under different dosages. Chin. J. Infect. Dis., 21(6):423-424 (in Chinese).

[28]Zhang, W., Lin, C., Han, L., Li, L., Gao, P., Lin, H., Gong, X., Huang, F., Tang, Y., Ma, J., 2010. Study on the immuno-effects and influencing factors of Chinese Hamster Ovary (CHO) cell hepatitis B vaccine among adults, under different dosages. Chin. J. Epidemiol., 31(7):767 (in Chinese).

[29]Zuckerman, J., Langer, B., 2005. Hepatitis B vaccination in a school age population: a feasibility study. J. Med. Virol., 76(1):47-54.

Open peer comments: Debate/Discuss/Question/Opinion

<1>

Please provide your name, email address and a comment





Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou 310027, China
Tel: +86-571-87952276; Fax: +86-571-87952331; E-mail: jzus@zju.edu.cn
Copyright © 2000~ Journal of Zhejiang University-SCIENCE